YIM

YIM Session 3: T-cell Engaging Therapies in CLL

Friday, September 12, 2025

11:05 - 12:00 CEST

Location: ICE, Theater Hall (S2), Entrances On Level 0 & 1

Co-Chair(s)

Philip Thompson, MB, BS (Hons)

Consultant Haematologist
Peter MacCallum Cancer Centre & Royal Melbourne Hospital; The Sir Peter MaCallum Department of Clinical Oncology, University of Melbourne
Melbourne, Victoria, Australia
Erin Parry, MD, PhD

Physician, Assistant Professor of Medicine
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States

11:05 - 11:15 CEST

Unravelling the Clinical and Biological Features of Accelerated Chronic Lymphocytic Leukemia
Primary Author / Presenter: Francesco Angotzi, MD – Hematology Unit, University of Padova
11:15 - 11:25 CEST

Venetoclax in combination with chemotherapy in Richter Syndrome patients: a real-life experience
Primary Author / Presenter: Laura Ballotta, MD – Hematology Unit, ASUGI Azienda Universitaria Giuliano Isontina, Maggiore Hospital
11:25 - 11:35 CEST

Central Nervous System Involvement in Patients with Richter Transformation
Primary Author / Presenter: Domitilla Baccon – Department of Hematology, Mayo Clinic
11:35 - 11:45 CEST

Single-cell transcriptome analysis reveals molecular mechanism of stem-like cells in Richter Transformation
Primary Author / Presenter: Ziyuan Zhou, MD – Department of Hematology, the First Affiliated Hospital with Nanjing Medical University, Jiangsu Province Hospital, Nanjing Medical University
11:45 - 12:00 CEST

Panel Discussion